RSV season is upon us, which means thousands of children under five years of age and hundreds of thousands of adults will be ...

FDA has approved Abrysvo for active immunization for the prevention of lower respiratory tract disease caused by RSV.

Starting today, Ontarians can receive their free flu shot and the new, updated COVID-19 vaccine at local pharmacies, public ...

The British pharma’s experience during the third quarter mirrored that of rival Pfizer, which also reported lower sales of ...

The bivalent RSV prefusion F vaccine (Abrysvo) demonstrated 90% vaccine effectiveness (VE) in high-risk adults against ...

That means that if you haven’t gotten vaccines already, it’s time to put them on your to-do list. But which ones should you ...

GSK stock crumbled on Wednesday after vaccine sales tumbled, leading to a third-quarter miss. Revenue from RSV shot Arexvy ...

To hear GSK CEO Emma Walmsley tell it, the third quarter presented “some challenges” for the drugmaker. | To hear GSK CEO ...

A solid showing for HIV drugs sold by majority-owned ViiV Healthcare and speciality medicines like cancer therapies Zejula ...

New guidelines and the timing of COVID vaccinations impacted uptake of Abrysvo this year, according to a company executive.

We think the market is overly bearish about Pfizer’s ability to right the ship, and we see shares as undervalued.

As fall approaches, so does respiratory syncytial virus or RSV season. This year, there are more options for those most ...